Sublingual immunotherapy abrogates seasonal bronchial hyperresponsiveness in children with Parietaria-induced respiratory allergy: A randomized controlled trial

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 59, Issue 8, 2004, Pages 883-887

  Pajno, G B ^a   Passalacqua, G ^b,d   Vita, D ^a   Caminiti, L ^a   Parmiani, S ^c   Barberio, G ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Alk Abello'   (Italy)

^d Allergy and Respiratory Diseases   (Italy)

Author keywords

Allergic asthma; Bronchial hyperresponsiveness; Parietaria pollen; Sublingual immunotherapy

Indexed keywords

METHACHOLINE; PLACEBO; POLLEN ANTIGEN;

ADOLESCENT; ALLERGIC REACTION; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; IMMUNOTHERAPY; LUNG FUNCTION TEST; MALE; PARIETARIA; POLLEN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT ALLERGY; SCHOOL CHILD; SEASON; STATISTICAL SIGNIFICANCE; WINTER;

ADOLESCENT; ASTHMA; BRONCHIAL HYPERREACTIVITY; CHILD; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LUNG; MALE; PARIETARIA; POLLEN;

EID: 3442885192     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2004.00578.x     Document Type: Article

References (37)

1. WEEKE B. The future for immunotherapy. Clin Exp Allergy 1991;21:86-92.
2. HENRY R, LANDAU L, MELLIS C, VAN ASPEREN P, MORTON J, COOPER P et al. Childhood asthma application of the international view of management in Australia and New Zealand. J Paed Child Health 1990;26:72-74.
3. WARNER JO. Evidence-based pediatric allergy practice. Pediatr Allergy Immunol 2001;12:293-294.
4. BOUSQUET J, MALLING HJ. WHO Position Paper. Allergen immunotherapy: therapeutic vaccines for allergic disease. Allergy 1998;53(Suppl. 44):1-42.
5. FREW AJ. Injection immunotherapy. British Society for Allergy and Clinical Immunology Working Party. BMJ 1993;307:919-923.
6. ABRAMSON M, PUY R, WEINER J. Immunotherapy in asthma: an updated systematic review. Allergy 1999;54:1022-1041.
7. ROSS RN, NELSON HS, FINEGOLD I. Effectiveness of specific immunotherapy in the treatment of asthma: a meta-analysis of prospective randomised double-blind placebo-controlled study. Clin Ther 2000;22:329-341.
8. BOUSQUET J, VAN DE CAUWENBERGE P, eds. Allergic rhinitis and its impact on asthma (ARIA). WHO position paper. J Allergy Clin Immunol 2001;108(5 Part 2):S147-S334.
9. CANONICA GW, PASSALACQUA G. Non-injection routes for immunotherapy. J Allergy Clin Immunol 2003;111:437-448.
10. WILSON DR, TORRES LI, DURHAM SR. Sublingual immunotherapy for allergic rhinitis (Cochrane review). Cochrane Database Syst Rev 2003:CD002893.
11. BOUSQUET J, SCHEINMANN P, GUINNEPAIN MT, PERRIN-FAVOLLE M, SAUVAGET J, TONNEL AB et al. Sublingual swallow immunotherapy (SLIT) in patients with asthma due to house dust mites: a double blind placebo controlled study. Allergy 1999;54:249-260.
12. PRADALIER A, BASSET D, CLAUDEL A, COUTURIER P, WESSEL F, GALVIN S et al. Sublingual swallow immunotherapy (SLIT) with a standardized five grass pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis. Allergy 1999;54:819-828.
13. PASSALACQUA G, ALBANO M, FREGONESE L, RICCIO A, PRONZATO C, MELA GS et al. Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis. Lancet 1998;351:629-632.
14. PAJNO GB, VITA D, PARMIANI S, CAMINITI L, LA GRUTTA S, BARBERIO G. Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with fluticasone dipropionate. Clin Exp Allergy 2003;33:1641-1647.
15. CARREIRA J, RUBIO M, HERRERO T, HORAK F, BUSINCO L, WUTHRICH B et al. Collaborative clinical assay of the biological potency of allergen skin tests extracts. Clin Allergy 1984;14:503-507.
16. CHAI H, FARR RS, FROEHLICH LA, MATHISON DA, MCLEAN JA, ROSENTHAL RR et al. Standardization of bronchial inhalation challenge procedures. Allergy Clin Immunol 1975;56:323-327.
17. TROISE C, VOLTOLINI S, CANESSA A, PECORA S, NEGRINI AC. Sublingual immunotherapy in Parietaria pollen-induced rhinitis: a double blind study. J Invest Allergol Clin Immunol 1995;5:25-30.
18. PURELLO-D'AMBROSIO F, GANGEMI S, ISOLA S, LA MOTTA N, PUCCINELLA P, PARMIANI S et al. Sublingual immunotherapy: a double-blind, placebo-controlled trial with Parietaria judaica extract standardised in mass units in patients with rhinoconjunctivitis, asthma, or both. Allergy 1999;54:968-973.
19. LA ROSA M, RANNO C, ANDRE C, CARAT F, TOSCA MA, CANONICA GW. Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 1999;104:425-432.
20. PASSALACQUA G, ALBANO M, RICCIO A, FREGONESE L, PUCCINELLI P, PARMIANI S et al. Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: a double-blind, placebo-controlled trial. J Allergy Clin Immunol 1999;104:964-968.
21. HEDLIN G, WILLE S, BROWALDH L, HILDEBRAND H, HOLMGREN D, LINDFORS A et al. Immunotherapy in children with allergic asthma: effect on bronchial hyperreactivity and pharmacotherapy. J Allergy Clin Immunol 1999;103:609-614.
22. PIFFERI M, BALDINI G, MARRAZZINI G, BALDINI M, RAGAZZO V, PIETROBELLI A et al. Benefits of immunotherapy with a standardized Dermatophagoides pteronyssinus extract in asthmatic children: a three-year prospective study. Allergy 2002;57:785-790.
23. GREMBIALE RD, CAMPOROTA L, NATY S, TRANFA CM, DJUKANOVIC R, MARSICO SA. Effects of specific immunotherapy in allergic rhinitic individuals with bronchial hyperresponsiveness. Am J Respir Crit Care Med 2000;162:2048-2052.
24. MURRAY AB, FERGUSON AC, MORRISON BJ. Non-allergic bronchial hyperreactivity in asthmatic children decreases with age and increases with mite immunotherapy. Ann Allergy 1985;54:541-544.
25. OHMAN JL Jr, FINDLAY SR, LEITERMANN KM. Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of in vivo and in vitro responses. J Allergy Clin Immunol 1984;74:230-239.
26. VAN BEVER HP, STEVENS WJ. Effect of hyposensitization upon the immediate and late asthmatic reaction and upon histamine reactivity in patients allergic to house dust mite (Dermatophagoides pteronyssinus). Eur Respir J 1992;5:318-322.
27. SUNDIN B, LILJA G, GRAFF-LONNEVIG V, HEDLIN G, HEILBORN H, NORRLIND K et al. Immunotherapy with partially purified and standardized animal dander extracts. I. Clinical results from a double-blind study on patients with animal dander asthma. J Allergy Clin Immunol 1986;77:478-487.
28. BOUSQUET J, CALVAYRAC P, GUERIN B, HEJJAOUI A, DIUVERT H, HEWITT B et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. I. In vivo and in vitro parameters after a short course of treatment. J Allergy Clin Immunol 1985;76:734-744.
29. VAN BEVER HP, STEVENS WJ. Suppression of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus). Clin Exp Allergy 1989;15:399-404.
30. ROHATGI N, DUNN K, CHAI H. Cat- or dog-induced immediate and late asthmatic responses before and after immunotherapy. J Allergy Clin Immunol 1988;82:389-397.
31. LOMBARDI C, GARGIONI S, VENTURI S, ZOCCALI P, CANONICA GW, PASSALACQUA G. Controlled study of preseasonal immunotherapy with grass pollen extract in tablets: effect on bronchial hyperreactivity. J Investig Allergol Clin Immunol 2001;11:41-45.
32. WALKER SM, PAJNO GB, TORRES LIMA M, WILSON DR, DURHAM SR. Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial. J Allergy Clin Immunol 2001;107:87-93.
33. DURHAM SR, TILL SJ. Immunological changes associated with allergen immunotherapy. J Allergy Clin Immunol 1998;102:157-164.
34. IPPOLITI F, DE SANTIS W, VOLTERRANI A, LENTI L, CANITANO N, LUCARELLI S et al. Immunomodulation during sublingual therapy in allergic children. Pediatr Allergy Immunol 2003;14:216-221.
35. MITZNER W, BROWN RH. Potential mechanism of hyperresponsive airways. Am J Respir Crit Care Med 2000;161:1619-1623.
36. FERGUSON A. Correlation of bronchial eosinophils and mast cells with bronchial hyperresponsiveness in children with asthma. J Allergy Clin Immunol 1992;90:609-613.
37. CHETTA A, FORESI A, DEL DONNO M, CONSIGLI GF, BERTORELLI G, PESCI A et al. Bronchial responsiveness to distilled water and methacholine and its relationship to inflammation and remodelling in asthma. Am J Respir Crit Care Med 1996;153:910-917.